Serum levels of HMGB1 have been associated with micro-inflammatory states in continuous ambulatory peritoneal dialysis (CAPD) patients, and inhibition of HMGB1 has a protective effect on peritoneal function in experimental models of peritonitis (Zhu et al., 2011; Cao et al., 2013). This evidence concerns the gene HMGB1 and peritonitis.